A study presented today at the International Association for the Study of Lung Cancer 2024 World Conference on Lung Cancer demonstrated a promising pathway toward developing predictive biomarkers for immune checkpoint inhibitors.
Pharmalittle: We’re reading about a new schizophrenia drug, a U.N. pledge on AMR and more
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal